Considering the homodimer formation of the RevTM CEA-IgG4-7B6 resulting in two binding arms towards CEA, it most likely binds more efficiently to CEA-expressing tumor cells than the monovalent RevTM CEA-7B6. Here, CEACAM5 is linked to neoplasm.